Please use this identifier to cite or link to this item:
|Title:||Chronopharmacology of prednisolone in rheumatoid arthritis|
Azzopardi, Lilian M.
|Keywords:||Prednisolone -- Therapeutic use -- Effectiveness|
Rheumatoid arthritis -- Chemotherapy -- Evaluation
Physicians -- Attitudes
|Publisher:||University of Malta. Department of Pharmacy|
|Citation:||Attard, C., Grech, L., Serracino-Inglott, A., & Azzopardi, L. M. (2015, October). Chronopharmacology of prednisolone in rheumatoid arthritis. Poster session presented at the ACCP Global Conference on Clinical Pharmacy, San Francisco, USA.|
|Abstract:||A poster presentation regarding chronopharmacology of prednisolone in rheumatoid arthritis. Introduction: The pharmacodynamic effect of prednisolone is often measured via cortisol and blood lymphocytes in the plasma – both of which exhibit circadian rhythms. In addition, rheumatoid arthritis (RA) is known to exhibit a diurnal rhythm, with patients experiencing most symptoms in the morning. Aims: 1. To identify the relationship between pain levels and the time at which prednisolone is administered in rheumatoid arthritis. 2. To obtain physician perspective on the chronopharmacology of prednisolone.|
|Appears in Collections:||Scholarly Works - FacM&SPha|
Files in This Item:
|Chronopharmacology_of_prednisolone_in_rheumatoid_arthritis_2015.pdf||647.11 kB||Adobe PDF||View/Open|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.